Oracle (ORCL) PT Lowered to $325 at UBS, but Buy Rating Reiterated Despite Q2 Miss
Tweet Send to a Friend
UBS analyst Karl Keirstead lowered the price target on Oracle (NYSE: ORCL) to $325.00 (from $380.00) while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
